|
|
Volumn 50, Issue 12, 2011, Pages 1617-1618
|
|
First line therapy for local advanced or metastasized urothelial carcinoma : Randomized double-blind phase II study to compare gemcitabin and cisplatin in combination with OGX-427 or placebo for advanced transitional cell carcinoma of the bladder (OGX-427 - AB 39/11 of the Working Group Urological Oncology);First-line-Therapie beim lokal fortgeschrittenen oder metastasierten Urothelkarzinom : Randomisierte, doppelblinde Phase-II-Studie zum Vergleich von Gemcitabin und Cisplatin in Kombination mit OGX-427 oder Placebo bei fortgeschrittenem Transitionalzellkarzinom der Blase (OGX-427 - AB 39/11 der AUO)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
GEMCITABINE;
OGX 427;
PLACEBO;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
BLADDER CARCINOMA;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
HUMAN;
METASTASIS;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
TRANSITIONAL CELL CARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, TRANSITIONAL CELL;
CISPLATIN;
DEOXYCYTIDINE;
DOUBLE-BLIND METHOD;
HUMANS;
PLACEBO EFFECT;
TREATMENT OUTCOME;
URINARY BLADDER NEOPLASMS;
|
|
EID: 83655201600
PISSN: 03402592
EISSN: 14330563
Source Type: Journal
DOI: 10.1007/s00120-011-2768-3 Document Type: Short Survey |
|
Times cited : (4)
|
|
References (0)
|
